$BLLN

Johnson Nancy JoAnn sold $1.4M of BLLN

Johnson Nancy JoAnn (See Remarks) sold 14,000 shares of BillionToOne, Inc. (BLLN) at an average of $100.18 ($99.09–$102.34, $1.40M total) across 7 trades over 2026-06-08 to 2026-06-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Johnson Nancy JoAnn
Published Jun 11, 2026, 12:36 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 1:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling size, timing, and whether it was pre-arranged; it does not include operational or financial performance updates.

02

Market read

A $1.40M officer sale is a modest sentiment input, but the 10b5-1 structure limits interpretive value versus discretionary selling.

03

What to watch

Traders may overreact to insider sales; the key is whether there are concurrent news catalysts (earnings, trial updates, financing) not present in this filing.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-10; transaction dates 2026-06-08 to 2026-06-09

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for BillionToOne, Inc.

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

Officer Nancy JoAnn Johnson sold $1.40M of BillionToOne shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Near-term price reaction, if any, is likely limited; watch for follow-through in volume rather than a directional catalyst.

Evidence & confidence

The filing is a routine insider transaction and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • BillionToOne, Inc.

    Company whose officer executed open-market sales disclosed on Form 4.

  • Nancy JoAnn Johnson

    Officer who sold 14,000 shares (weighted avg ~$100.18) under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.